http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18302413

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 612
issn 1521-009X
0090-9556
issueIdentifier 7
pageRange 603-612
publicationName Drug metabolism and disposition: the biological fate of chemicals
startingPage 603
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2de62851aee5825eefb200d2346ccd5
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f944735a1ba6c609c4e97d8400328d19
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4265e1bfe5b5f646d6afa8af957dfb6f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1480144a2af335929d1a80110a1ffce3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_82e9bf4191870f28ddd53d00d3f544b2
bibliographicCitation Miller SR, Hau RK, Jilek JL, Morales MN, Wright SH, Cherrington NJ. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2. Drug Metab Dispos. 2020 Jul;48(7):603–12. PMID: 32393653; PMCID: PMC7318791.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2575-8059
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b561eda5e61c32719755054edaf4c20c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc0cd0d24e2036c32f24ce34c269e831
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3925c35a6c6ab0e96b63660e29b8521b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fa175bdc7485b28ff704004f5db34ca
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a6891735d1746e0847069b3e43b0729
date 2020-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC7318791
https://doi.org/10.1124/dmd.120.090720
https://pubmed.ncbi.nlm.nih.gov/32393653
isPartOf https://portal.issn.org/resource/ISSN/1521-009X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3444
https://portal.issn.org/resource/ISSN/0090-9556
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2
discusses http://id.nlm.nih.gov/mesh/M0285219
http://id.nlm.nih.gov/mesh/M0023377
http://id.nlm.nih.gov/mesh/M0270202
http://id.nlm.nih.gov/mesh/M0028255
http://id.nlm.nih.gov/mesh/M0404007
http://id.nlm.nih.gov/mesh/M0015066
http://id.nlm.nih.gov/mesh/M0404011
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D033722Q000378
http://id.nlm.nih.gov/mesh/D001814Q000378
http://id.nlm.nih.gov/mesh/D018894Q000493
http://id.nlm.nih.gov/mesh/D009705Q000493
http://id.nlm.nih.gov/mesh/D033721Q000378
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015215Q000493
http://id.nlm.nih.gov/mesh/D020128
http://id.nlm.nih.gov/mesh/D006367
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004353Q000379
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_87857dfb59266067e4e4477ec2f2f9c3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f4b7957b04ca6fb9af075094011e1241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6029
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398508
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c63c58f7b57cec21b38e62d5653051d3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60877
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_96817f926d2f3b8f3c0dd19c9d4bb003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65407

Total number of triples: 65.